Archive for 'Medical devices'

Self-expanding stents to treat the silent killer : aneurysm

Self-expanding stents to treat the silent killer : aneurysm

The continuous flow in jet-induced fountains inspired Nourredine Frid, CEO at Cardiatis (Isnes), to apply the theory of fluid mechanics to blood vessels. By converting turbulence to laminar flow in a blood vessel, an aneurysm (a [...]

Growth boost for KitoZyme: world-leader in vegetal chitosan production

Growth boost for KitoZyme: world-leader in vegetal chitosan production

  KitoZyme, a SME located in Herstal (Belgium), is the only company in the world to provide chitosan and chitin-glucan manufactured from non-animal and non-GMO sources. Lately, KitoZyme has a strong record of technological and commercial [...]

Nyxoah, awarded for its neurostimulation implant

Nyxoah, awarded for its neurostimulation implant

Nyxoah, a clinical-stage medical device company located in Mont-Saint-Guibert (Belgium), is gaining worldwide recognition as it won the Frost & Sullivan New Product Innovation Leadership Award (2014) as well as the World Technology Award (2014) for [...]

Synolyne Pharma gets new patents granted in Europe and in the US

Synolyne Pharma gets new patents granted in Europe and in the US

Synolyne Pharma, a biotech spin-off company of the University of Liège and spin-out of Kitozyme SA (Belgium), has recently been granted two new patents in both Europe and the United States in relation to its chitosan-based [...]

KTO’s and their spin-offs playing a key role in the land of innovation (Part1/2)

KTO’s and their spin-offs playing a key role in the land of innovation (Part1/2)

NautaDutilh, a law firm involved in the various development stages of spin-offs conducted a survey entitled “Belgian TTO’s and their spin-offs: a match made in heaven?”. One of the main goals of the survey was to [...]

KTO’s and their spin-offs playing a key role in the land of innovation (Part2/2)

KTO’s and their spin-offs playing a key role in the land of innovation (Part2/2)

NautaDutilh, a law firm involved in the various development stages of spin-offs conducted a survey entitled “Belgian TTO’s and their spin-offs: a match made in heaven?”. One of the main goals of the survey was to [...]

Medi-Line and the CHU of Liège launch an innovative medical device to treat male urinary incontinence.

Medi-Line and the CHU of Liège launch an innovative medical device to treat male urinary incontinence.

MEDI-LINE and the CHU of Liège have recently launched the Tom-Sling®, a new medical device that allows treating male urinary incontinence that occurs after radical prostatectomy for prostate cancer. The surgical procedure, safe and effective, and [...]

Intuitim, Spin-off of UCL discovers potential market in China for specialized medical imaging device

Intuitim, Spin-off of UCL discovers potential market in China for specialized medical imaging device

For Intuitum, it all began at UCL in 2012, with a project aimed at developing innovative tools for medical imaging. Intuitim, founded by Vincent Nicolas and Edouard Delvaulx, stemming from the laboratory of professor Benoît Macq [...]

Building bones from fat cells: UCL’s Cell and Tissue Therapy Center (CTTC) develop revolutionary technique

Building bones from fat cells: UCL’s Cell and Tissue Therapy Center (CTTC) develop revolutionary technique

Belgian researcher Denis Dufrane and his team of researchers from the University of St. Luc’s (UCL) Cell and Tissue Therapy Center (CTTC) have developed a revolutionary technique that consists of producing a three-dimensional “modeling-clay-like” osseous structure [...]

Synolyne Pharma raises its capital by € 3.3 million and sets off to market its product against degenerative osteoarthritis

Synolyne Pharma raises its capital by € 3.3 million and sets off to market its product against degenerative osteoarthritis

  Updating on a story from 2012, the spin-off of ULg, Synolyne Pharma has raised € 3,3 million to pursue the development of its treatment against degenerative osteoarthritis and in addition, sign an agreement with KitoZyme [...]